Ferozsons Laboratories (KAR:FEROZ) Total Equity: ₨15,212 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KAR:FEROZ Ferozsons Laboratories Ltd KAR:FEROZ
70 GF Score
Price ₨386.48
GF Value ₨420.92
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Ferozsons Laboratories Total Equity?

Ferozsons Laboratories KAR:FEROZ +0.26% 70 Total Equity is ₨15,212 Mil as of Mar. 2026. GuruFocus rates KAR:FEROZ with a GF Score™ of 70/100 and a GF Value™ of ₨420.92 (Fairly Valued). The stock has 3 warning signs investors should review.

Ferozsons Laboratories's total equity for the quarter that ended in Mar. 2026 was ₨15,212 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Ferozsons Laboratories Total Equity Historical Data

* Premium members only.

The historical data trend for Ferozsons Laboratories's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ferozsons Laboratories Total Equity Chart

Ferozsons Laboratories Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,892.41 8,298.47 8,363.57 11,820.18 14,466.69

Ferozsons Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14,211.35 14,466.69 14,788.64 14,959.21 15,212.50
KAR:FEROZ
70GF Score
Ferozsons Laboratories Ltd KAR:FEROZ
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ferozsons Laboratories Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Ferozsons Laboratories's Total Equity for the fiscal year that ended in Jun. 2025 is calculated as

Total Equity=Total Assets(Q: Jun. 2025 )-Total Liabilities(Q: Jun. 2025 )
=24604.947-10138.259
=14,467

Ferozsons Laboratories's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=26462.806-11250.31
=15,212

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ₨15,212 Mil mean?
Ferozsons Laboratories (KAR:FEROZ) has a Total Equity of ₨15,212 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Ferozsons Laboratories and its competitors.
Is Ferozsons Laboratories' Total Equity too high?
Ferozsons Laboratories' current Total Equity is ₨15,212 Mil. Overall, Ferozsons Laboratories has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ferozsons Laboratories' Total Equity compare to ZTS and UTHR?
Ferozsons Laboratories' Total Equity of ₨15,212 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Ferozsons Laboratories and its competitors. Ferozsons Laboratories's current Total Equity is ₨15,212 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ferozsons Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Ferozsons Laboratories (KAR:FEROZ) is currently considered Fairly Valued. The stock's GF Value™ is ₨420.92, compared to a current price of ₨386.48 — trading 8.2% below its estimated fair value. The current Total Equity is ₨15,212 Mil. Ferozsons Laboratories' overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Ferozsons Laboratories (KAR:FEROZ), the current Total Equity is ₨15,212 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ferozsons Laboratories (KAR:FEROZ) Overvalued in 2026?

Based on GuruFocus' analysis, Ferozsons Laboratories stock appears to be undervalued. The current stock price of ₨386.48 is trading 8.2% below its estimated GF Value™ of ₨420.92. GuruFocus considers Ferozsons Laboratories to be Fairly Valued.

Key valuation signals for KAR:FEROZ:

  • Total Equity: ₨15,212 Mil
  • GF Value™: ₨420.92 vs. price of ₨386.48 (8.2% below fair value)
  • GF Score™: 70/100 with 3 warning signs

No single metric tells the full story. See the KAR:FEROZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ferozsons Laboratories Business Description

Address 5 K.M Sunder Raiwind Road, Lahore, PB, PAK
Ferozsons Laboratories Ltd is a pharmaceutical company. It is engaged in the import, manufacture, and sale of pharmaceuticals products and medical devices. The company operates in the therapeutic areas of dermatology, anti-infective treatments, gastroenterology, hepatology, cardiology, and diabetes. It manufactures tablets, capsules, syrups, suspensions, creams, and ointments. The company operates in three segments namely Ferozsons, BF Biosciences, and Others. The group sells its products in Pakistan and internationally, of which the majority of the revenue is generated from the sales made in Pakistan.
70GF Score

Get the complete analysis for KAR:FEROZ

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨386.48
Price
₨420.92
GF Value